FACTOID # 146: About one-quarter of all nations drive on the left-hand-side of the road. Most of them are former British colonies.
 
 Home   Encyclopedia   Statistics   Countries A-Z   Flags   Maps   Education   Forum   FAQ   About 
 
WHAT'S NEW
RECENT ARTICLES
More Recent Articles »
 

FACTS & STATISTICS    Simple view

  1. Select countries to view: (hold down Control key and click to select several)

     

     

    Compare:

     

     

  1. Select fact or statistic: (* = graphable)

     

     

     

  2. (OPTIONAL) Compare to statistic: (both need to be graphable)

     

     

     

  3. View result as:

     

       
(OR) SEARCH ALL encyclopedia, stats & forums:   

Encyclopedia > Shire Pharmaceuticals Group

Shire Pharmaceuticals Group plc is a British manufacturer of pharmaceuticals including Adderall XR, Carbatrol, and Fosrenol. Founded in 1986, Shire had revenues for the full year 2004 of $1,363.2 million and an operating income of $446.4 million. The growth rates for revenues were 13% for 2004 over the prior year. Pharmacology (in Greek: pharmacon (φάρμακον) meaning drug, and logos (λόγος) meaning science) is the study of how chemical substances interact with living systems. ... Adderall® CII is a pharmaceutical amphetamine usually used to treat attention deficit disorder, attention-deficit hyperactivity disorder, and narcolepsy. ... Carbamazepine (Biston®; Calepsin®; Carbatrol®; Epitol®; Finlepsin®; Sirtal®; Stazepine®; Tegretol®; Telesmin®; Timonil®; Equetro®) is an anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy and bipolar disorder; but also used to treat schizophrenia and trigeminal neuralgia. ... Fosrenol, known generically as lanthanum carbonate, is a medication within the phosphate binder class. ...

Contents


Corporate Strategy

Shire’s strategic goal is to become the leading specialty pharmaceutical company, focusing on meeting the needs of specialist physicians. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results. To this end, Shire focuses its business on medications in the areas of central nervous system (CNS), gastrointestinal (GI), general products (GP) and human genetic therapies (HGT), all areas where Shire currently has a commercial presence. A diagram showing the CNS: 1. ... For the Physics term GUT, please refer to Grand unification theory The gastrointestinal or digestive tract, also referred to as the GI tract or the alimentary canal or the gut, is the system of organs within multicellular animals which takes in food, digests it to extract energy and nutrients, and... Genetics (from the Greek genno γεννώ= give birth) is the science of genes, heredity, and the variation of organisms. ...


The structure is sufficiently flexible to allow Shire to target new therapeutic areas through acquisitions. This approach aims to deliver increased returns and lower risks. Shire’s in-licensing and merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the U.S. or Europe. The phrase mergers and acquisitions (M&A) refers to the aspect of business strategy and management dealing with the merging and/or acquiring of different companies. ... Intellectual property (IP) refers to a legal entitlement which sometimes attaches to the expressed form of an idea, or to some other intangible subject matter. ...


Corporate Leadership

Matthew Emmens is the Chief Executive Officer and Chairman of the Executive Committee. The non-executive Board Chairman is Dr. James Cavanaugh. A chief executive officer (CEO) or chief executive is the highest-ranking corporate officer or executive officer of a corporation, company, or agency. ...


Key Marketed Products and Indications

Adderall® CII is a pharmaceutical amphetamine usually used to treat attention deficit disorder, attention-deficit hyperactivity disorder, and narcolepsy. ... DISCLAIMER Please remember that Wikipedia is offered for informational use only. ... Adderall® CII is a pharmaceutical amphetamine used to treat attention-deficit hyperactivity disorder and narcolepsy. ... DISCLAIMER Please remember that Wikipedia is offered for informational use only. ... Carbamazepine (Biston®; Calepsin®; Carbatrol®; Epitol®; Finlepsin®; Sirtal®; Stazepine®; Tegretol®; Telesmin®; Timonil®; Equetro®) is an anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy and bipolar disorder; but also used to treat schizophrenia and trigeminal neuralgia. ... Carbamazepine (sold under the brand-names Biston, Calepsin, Carbatrol, Epitol, Equetro, Finlepsin, Sirtal, Stazepine, Tegretol, Telesmin, Timonil) is an anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy and bipolar disorder. ... Bipolar disorder (which used to be called, and is still colloquially referred to as manic depression) is a diagnostic category describing a class of mood disorders where the person experiences states of depression and/or mania and/or hypomania, and/or mixed states. ... Fosrenol, known generically as lanthanum carbonate, is a medication within the phosphate binder class. ... Hyperphosphatemia is an electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood. ... Kidneys viewed from behind with spine removed The kidneys are bean-shaped excretory organs in vertebrates. ... Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug used to treat inflammation of the rectum, mild to moderate ulcerative colitis and inflammation of the lower colon. ... Galantamine (trade name Razadyne®, Reminyl®) is a medication used in the treatment of Alzheimers disease. ... Anagrelide (Agrylin®/Xagrid®, Shire) is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). ... Anagrelide (Agrylin®/Xagrid®, Shire) is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). ... Essential thrombocytosis (ET, essential thrombocythemia) is a rare and chronic blood disorder characterized by the overproduction of megakaryocytes (the precursor cell for platelets. ...

Financial Information

Shire is traded on three stock exchanges:

  1. The London Stock Exchange, where its symbol is SHP.L. Shire is a constituent of the FTSE 100 Index.
  2. The NASDAQ, where its symbol is SHPGY.
  3. The Toronto Stock Exchange, where its symbol is SHQ.TO.

Shire's financial reports can be found at http://www.shire.com/shire/InvestorRelations/reports.jsp?tn=2&m1=22. The Source by Greyworld, in the new LSE building Paternoster Square. ... The Financial Times Stock Exchange Index of 100 Leading Shares, or FTSE 100 Index (pronounced footsie), is a share index of the 100 largest companies listed on the London Stock Exchange. ... NASDAQ (originally an acronym for National Association of Securities Dealers Automated Quotations ) is a U.S. electronic stock exchange. ... Former logo of the Toronto Stock Exchange prior to the switch to TSX. The Toronto Stock Exchange (TSX) is Canadas largest stock exchange, and the division of the TSX Group that holds senior equities. ...


Locations

The corporate offices are located in Basingstoke, Hampshire. The address is:
Location within the British Isles View from Basingstoke railway station forecourt; the chrome yellow buildings stand on the site of older office buildings that have been demolished to build apartments. ... Hampshire (abbr. ...

Hampshire International Business Park
Chineham Basingstoke
Hampshire
RG24 8EP
United Kingdom

Other major offices are located in the United States in Wayne, Pennsylvania and Cambridge, Massachusetts. Plus, Shire owns a manufacturing site in Owings Mills, Maryland. Wayne is a community within the Main Line of Pennsylvania. ... Nickname: City of Squares Official website: www. ... Owings Mills is a census-designated place located in Baltimore County, Maryland. ...


External links

  • Official site
  • Yahoo profile

  Results from FactBites:
 
Commission Legal Brief: Gryl v. Shire Pharmaceuticals Group / June 21, 2002 (5343 words)
The plaintiffs allege that defendants acquired options in Shire Pharmaceuticals Group PLC ("Shire") while the defendants were directors of Shire and then exercised some of their options and sold the resultingShire stock within six months of acquiring the options.
The plaintiffs further contend that the Shire Board's approval was deficient in that it did not state that it was for the purpose of exempting the transactions from Section 16(b).
Most notably, the plaintiffs point to a Shire board resolution from six weeks before the merger became effective, which states that "conditional upon completion of the Merger and admission of the Consideration Shares to the Official List, [the defendants] are hereby appointed as non-executive directors of the Company" (A785).
  More results at FactBites »


 

COMMENTARY     


Share your thoughts, questions and commentary here
Your name
Your comments
Please enter the 5-letter protection code

Want to know more?
Search encyclopedia, statistics and forums:

 


Lesson Plans | Student Area | Student FAQ | Reviews | Press Releases |  Feeds | Contact
The Wikipedia article included on this page is licensed under the GFDL.
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms.